China SXT Pharmaceuticals, Inc. (SXTC)

China SXT Pharmaceuticals Revenue

China SXT Pharmaceuticals had revenue of $626.57K in the half year ending September 30, 2025, a decrease of -33.31%. This brings the company's revenue in the last twelve months to $1.54M, down -15.42% year-over-year. In the fiscal year ending March 31, 2025, China SXT Pharmaceuticals had annual revenue of $1.74M, down -9.73%.

• Revenue (ttm): $1.54M
• Revenue Growth: -15.42%
• P/S Ratio: 4.04
• Revenue / Employee: $20,506
• Employees: 75
• Market Cap: 6.21M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2025	1.74M	-187.59K	-9.73%
Mar 31, 2024	1.93M	-43.18K	-2.19%
Mar 31, 2023	1.97M	-630.60K	-24.23%
Mar 31, 2022	2.60M	-2.18M	-45.53%
Mar 31, 2021	4.78M	-384.70K	-7.45%
Mar 31, 2020	5.16M	-1.85M	-26.38%
Mar 31, 2019	7.01M	-7.21K	-0.10%
Mar 31, 2018	7.02M	2.14M	43.79%
Mar 31, 2017	4.88M	1.16M	31.27%
Mar 31, 2016	3.72M	-	-